ONESOURCE

Onesource Specialty Pharma LimitedNSELive
₹1,664.7-29.20 (-1.72%)

Market Open · NSE · INR

Open

₹1,705

High

₹1,705

Low

₹1,637

Prev Close

₹1,693.9

52-Week Range62% from low
₹1,114
₹2,002.5

Market Cap

₹19.42 K Cr

Mid Cap

P/E (TTM)

-

EPS

₹-6.44

Div Yield

-

P/B Ratio

3.27

ROE

-1.3%

Key Metrics

Forward P/E20.91
Book Value₹508.53
Debt/Equity0.22×
Revenue Growth0.5%
Profit Margin1.07%
Operating Margin21.40%
Volume3.73 L
Avg Volume (20d)3.09 L
Delivery %50.00%
Trades25,226

Analyst Ratings(4 analysts)

Buy

Target Price

₹2,037

+22.3% upside

Buy3
Strong Sell1
Low: ₹1,699Median: ₹2,074High: ₹2,300

Current price: ₹1,665

Upcoming Events

Earnings Date
24 Jul 2026

What If I Had Invested?

Chart data not available for this range

AI Analysis

Get AI-powered sentiment analysis, strengths, risks, and outlook for this stock.

AI Technical Analysis

Buy/sell zones with live web research

Get AI-generated buy zones, sell targets, stop-loss levels and a technical narrative — powered by AI with live web search for the latest news and analyst moves.

Patterns are measured on real price data, then AI-validated. Pattern detection is free when nothing clean is found.

About

HealthcareBiotechnology

OneSource Specialty Pharma Limited, a biopharmaceutical company, engages in the research, development, manufacture, and commercialization of biological drug products in various injectable formats in India, Ireland, the United States, and internationally. The company provides end-to-end contract deve...

onesourcecdmo.com1,412 employees

Technical Indicators

Loading sector benchmark…

Quality scores

Valuation bands

Intrinsic value calculators

Peer Comparison

Loading events…

Recent Filings (NSE)

Raw NSE filings — full text + attachments. Tap any row for an AI summary that explains what it means for the stock.

Institutional Deals(NSE)

Source: NSE India. Block deals ≥5L shares or ≥₹10Cr. Bulk deals ≥0.5% of shares.

Governance Scorecard

AlphaView composite

Fund Actions

Loading fund activity…

News

News sourced from RSS feeds. Headlines link to original articles.

Disclaimer: This is AI-generated educational information, not investment advice. Stock data is delayed by up to 15 minutes. Past performance does not guarantee future results. Please consult a SEBI-registered investment advisor before making investment decisions.